Livingstone advises on the sale of Dalberg Klinik AG to Finnish healthcare provider Mehiläinen OY

  • Nov 2021
  • Healthcare
  • M&A: Sell-Side
  • Pan-European

Livingstone acted as the exclusive M&A advisor to Dalberg Klinik AG (“Klinik”) Founder Dr. Jürgen Vey, on its sale to global healthcare provider Mehiläinen OY (“Mehiläine”).

Dalberg Klinik is a high-quality “Plankrankenhaus” for orthopedic surgery, offering integrated inpatient/outpatient healthcare services since 2010. Mehiläinen is a quickly growing, international healthcare company founded in Finland in 1909. Mehiläinen offers a broad spectrum of healthcare services, including digital healthcare solutions.

As part of its internationalization strategy, the Company is expanding into the German market by acquiring the Dalberg Klinik. “We were looking for a hospital that stood out from the competition and could be used as a Buy & Build platform in Germany. Dalberg Klinik offered us an established infrastructure, a dedicated team, and the opportunity to grow. We have big plans for this hospital,” Commented Dr. Gerald Loos, Managing Director of Mehiläinen Deutschland.

Founder and sole shareholder of Dalberg Klinik, Dr. Jürgen Vey, led the hospital for many years as chief physician and CEO and is happy to be working with Mehiläinen on the next chapter of the hospital’s business development, “For us, it is a great honor that such a large and experienced healthcare provider as Mehiläinen has selected us for its first steps into the German market. I think the optimal mix of criteria around a healthy regional center like Fulda and the convincing characteristics of this hospital attracted Mehiläinen’s interest in the Dalberg Klinik. The German healthcare market urgently needs innovation, and Mehiläinen will be an enormous asset to inpatient and outpatient care in our region.

The acquisition contract between the Mehiläinen subsidiary Mehiläinen Deutschland GmbH and Dr. Vey was signed on November 11, 2021. Following the transaction, Dalberg Klinik’s experienced management team will be augmented by Mehiläinen’s Germany managing director, Dr. Gerald Loos, who will serve as Dalberg Klinik’s Chief Executive Officer. Dr. Jürgen Vey will remain Medical Director, Chief Physician, and member of the Dalberg Klinik Board of Directors.

The team will continue to grow and develop the Company together with the full support of the Mehiläinen Group. Mehiläinen’s objective is to expand the range of services offered to different customer groups and further develop the hospital’s outpatient component with best practices from Finland. Additional digital services will be introduced to complement and improve the availability and scope of healthcare services.

With the sale of Dalberg Klinik, we were able to successfully sell the second clinic with a focus on orthopedic surgery in the current year 2021, following the sale of Klinikgruppe Dr. Merkle to ATOS and Dalberg Klinik to Mehiläinen, thus demonstrating our strong position in the healthcare market. Livingstone is an active player in consolidating the German hospital and MVZ landscape. Currently, we are preparing a large number of healthcare transactions to go live in 2022,” comments Christian Grandin, Partner at Livingstone.

Share this page

Key Transaction Team

Stay up to date with our Newsletter